Jonathan Behr - Partner @ Dementia Discovery Fund

Overview

Number of Current Board & Advisor Roles

Number of Founded Organizations

Jonathan Behr is the Partner of Dementia Discovery Fund.

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Sudo Biosciences	Dementia Discovery Fund	—	Series B - Sudo Biosciences	obfuscated obfuscation
obfuscated obfuscation	Violet Therapeutics	Dementia Discovery Fund	Yes	Seed Round - Violet Therapeutics	obfuscated obfuscation
obfuscated obfuscation	QurAlis	Dementia Discovery Fund	—	Series B - QurAlis	obfuscated obfuscation
obfuscated obfuscation	Nitrase Therapeutics	Dementia Discovery Fund	—	Series A - Nitrase Therapeutics	obfuscated obfuscation
obfuscated obfuscation	QurAlis	Dementia Discovery Fund	Yes	Series A - QurAlis	obfuscated obfuscation
obfuscated obfuscation	Nitrase Therapeutics	Dementia Discovery Fund	Yes	Series A - Nitrase Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Inversago Pharma	JDRF T1D Fund	—	Series A - Inversago Pharma	obfuscated obfuscation
obfuscated obfuscation	Diasome Pharmaceuticals	JDRF T1D Fund	No	Venture Round - Diasome Pharmaceuticals	obfuscated obfuscation
obfuscated obfuscation	Tetragenetics	JDRF T1D Fund	—	Venture Round - Tetragenetics	obfuscated obfuscation

Number of Current Jobs

Number of Past Jobs

has

current jobs as

Partner

and

Managing Director

. Additionally,

has had

past jobs including

Executive in Residence and Market Sector Leader

Organization Name	Title At Company	Start Date	End Date
Mass General Brigham	Executive in Residence and Market Sector Leader	Dec 1, 2013	Dec 1, 2016
Exosome Diagnostics	Board Observer	Aug 1, 2015	Dec 1, 2016
Tilos Therapeutics	Co-founder	Jul 1, 2015	Aug 1, 2016
Breakthrough T1D	Managing Director	—	—

Number of Current Board & Advisor Roles

holds

board and advisor roles as

Board of Directors

and

Board Member

Hub Name	CB Rank (Hub)
Seed Stage Investors with Investments in Massachusetts	4,090
Venture Stage Investors with Investments in Cambridge, Massachusetts	16,754
Seed Stage Investors with Investments in New England	3,721
Neuroscience Companies	11,724
Early Stage Venture Investors with Investments in Massachusetts	2,331
Venture Capital Investors with Investments in Greater Boston Area	3,177
Venture Capital Investors with Investments in New England	2,935
Seed Stage Investors with Investments in Cambridge, Massachusetts	13,926
Venture Capital Investors with Investments in Cambridge, Massachusetts	12,696
Venture Stage Investors with Investments in Greater Boston Area	4,425